ATE418542T1 - Als ccr5-antagonisten verwendbare aryloxim- piperazine - Google Patents
Als ccr5-antagonisten verwendbare aryloxim- piperazineInfo
- Publication number
- ATE418542T1 ATE418542T1 AT02731174T AT02731174T ATE418542T1 AT E418542 T1 ATE418542 T1 AT E418542T1 AT 02731174 T AT02731174 T AT 02731174T AT 02731174 T AT02731174 T AT 02731174T AT E418542 T1 ATE418542 T1 AT E418542T1
- Authority
- AT
- Austria
- Prior art keywords
- aryloxim
- piperazine
- usable
- ccr5 antagonists
- ccr5
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27995001P | 2001-03-29 | 2001-03-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE418542T1 true ATE418542T1 (de) | 2009-01-15 |
Family
ID=23071025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02731174T ATE418542T1 (de) | 2001-03-29 | 2002-03-27 | Als ccr5-antagonisten verwendbare aryloxim- piperazine |
Country Status (19)
Country | Link |
---|---|
US (1) | US6689783B2 (de) |
EP (1) | EP1373206B1 (de) |
JP (1) | JP4303969B2 (de) |
KR (1) | KR20030083015A (de) |
CN (1) | CN1253435C (de) |
AR (1) | AR033622A1 (de) |
AT (1) | ATE418542T1 (de) |
AU (1) | AU2002303168B2 (de) |
CA (1) | CA2442210C (de) |
DE (1) | DE60230491D1 (de) |
ES (1) | ES2318009T3 (de) |
HK (1) | HK1057211A1 (de) |
HU (1) | HUP0400389A3 (de) |
IL (1) | IL157713A0 (de) |
MX (1) | MXPA03008801A (de) |
MY (1) | MY134019A (de) |
NZ (1) | NZ528011A (de) |
WO (1) | WO2002079157A1 (de) |
ZA (1) | ZA200307171B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7825121B2 (en) * | 1999-05-04 | 2010-11-02 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
PE20040769A1 (es) * | 2002-12-18 | 2004-11-06 | Schering Corp | Derivados de piperidina utiles como antagonisas ccr5 |
EP1725235B1 (de) * | 2004-02-05 | 2009-04-15 | Schering Corporation | Piperidin-derivate als ccr3-antagonisten |
HU229709B1 (en) | 2004-04-13 | 2014-05-28 | Incyte Corp Wilmington | Piperazinyilpiperidine derivatives as chemokine receptor antagonists |
US20070215685A1 (en) * | 2005-02-03 | 2007-09-20 | Yottamark, Inc. | System and Method of Product Identification Using a URL |
RU2411241C2 (ru) * | 2005-02-23 | 2011-02-10 | Шеринг Корпорейшн | Производные пиперидинилпиперазина, применимые в качестве ингибиторов хемокиновых рецепторов |
WO2008030853A2 (en) * | 2006-09-06 | 2008-03-13 | Incyte Corporation | Combination therapy for human immunodeficiency virus infection |
KR100830003B1 (ko) * | 2006-10-31 | 2008-05-15 | 씨제이제일제당 (주) | 결정성 s-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법 |
US20080173808A1 (en) * | 2007-01-18 | 2008-07-24 | Schering Corporation | Process and device for response normalized liquid chromatography nanospray ionization mass spectrometry (rnlc-nsi-ms) |
WO2013024022A1 (en) | 2011-08-12 | 2013-02-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for treatment of pulmonary hypertension |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4949314A (en) | 1966-08-16 | 1990-08-14 | The United States Of America As Represented By The Secretary Of The Navy | Method and means for increasing echo-ranging-search rate |
US4211771A (en) | 1971-06-01 | 1980-07-08 | Robins Ronald K | Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide |
US4518584A (en) | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
GB8327880D0 (en) | 1983-10-18 | 1983-11-16 | Ajinomoto Kk | Saccharomyces cerevisiae |
US4569790A (en) | 1984-03-28 | 1986-02-11 | Cetus Corporation | Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions |
US4530787A (en) | 1984-03-28 | 1985-07-23 | Cetus Corporation | Controlled oxidation of microbially produced cysteine-containing proteins |
US4604377A (en) | 1984-03-28 | 1986-08-05 | Cetus Corporation | Pharmaceutical compositions of microbially produced interleukin-2 |
IL76360A0 (en) | 1984-09-26 | 1986-01-31 | Takeda Chemical Industries Ltd | Mutual separation of proteins |
US4748234A (en) | 1985-06-26 | 1988-05-31 | Cetus Corporation | Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
NZ230045A (en) | 1988-08-05 | 1990-11-27 | Janssen Pharmaceutica Nv | 3-piperazinylbenzazole derivatives and pharmaceutical compositions |
US5368854A (en) | 1992-08-20 | 1994-11-29 | Schering Corporation | Use of IL-10 to treat inflammatory bowel disease |
US5464933A (en) | 1993-06-07 | 1995-11-07 | Duke University | Synthetic peptide inhibitors of HIV transmission |
TR199700801T1 (xx) | 1995-02-16 | 1998-03-21 | F. Hoffmann-La Roche Ag | İnterleukin 12 kullanılarak angiogenesisin önlenmesi. |
IL145741A0 (en) * | 1999-05-04 | 2002-07-25 | Schering Corp | Piperazine derivatives useful as ccrs antagonists |
-
2002
- 2002-03-27 AR ARP020101139A patent/AR033622A1/es unknown
- 2002-03-27 ES ES02731174T patent/ES2318009T3/es not_active Expired - Lifetime
- 2002-03-27 MX MXPA03008801A patent/MXPA03008801A/es active IP Right Grant
- 2002-03-27 IL IL15771302A patent/IL157713A0/xx unknown
- 2002-03-27 US US10/107,992 patent/US6689783B2/en not_active Expired - Fee Related
- 2002-03-27 AU AU2002303168A patent/AU2002303168B2/en not_active Expired - Fee Related
- 2002-03-27 HU HU0400389A patent/HUP0400389A3/hu unknown
- 2002-03-27 WO PCT/US2002/009490 patent/WO2002079157A1/en active IP Right Grant
- 2002-03-27 EP EP02731174A patent/EP1373206B1/de not_active Expired - Lifetime
- 2002-03-27 CA CA002442210A patent/CA2442210C/en not_active Expired - Fee Related
- 2002-03-27 CN CNB028076567A patent/CN1253435C/zh not_active Expired - Fee Related
- 2002-03-27 KR KR10-2003-7012566A patent/KR20030083015A/ko not_active Application Discontinuation
- 2002-03-27 JP JP2002577784A patent/JP4303969B2/ja not_active Expired - Fee Related
- 2002-03-27 DE DE60230491T patent/DE60230491D1/de not_active Expired - Lifetime
- 2002-03-27 NZ NZ528011A patent/NZ528011A/en unknown
- 2002-03-27 AT AT02731174T patent/ATE418542T1/de not_active IP Right Cessation
- 2002-03-28 MY MYPI20021141A patent/MY134019A/en unknown
-
2003
- 2003-09-12 ZA ZA200307171A patent/ZA200307171B/en unknown
-
2004
- 2004-01-06 HK HK04100067.4A patent/HK1057211A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20030087912A1 (en) | 2003-05-08 |
AU2002303168B2 (en) | 2005-10-06 |
CA2442210C (en) | 2009-09-08 |
JP2004524360A (ja) | 2004-08-12 |
KR20030083015A (ko) | 2003-10-23 |
US6689783B2 (en) | 2004-02-10 |
EP1373206A1 (de) | 2004-01-02 |
HUP0400389A2 (hu) | 2004-08-30 |
DE60230491D1 (de) | 2009-02-05 |
WO2002079157A1 (en) | 2002-10-10 |
AR033622A1 (es) | 2003-12-26 |
ZA200307171B (en) | 2004-12-13 |
MXPA03008801A (es) | 2004-02-18 |
MY134019A (en) | 2007-11-30 |
CN1500078A (zh) | 2004-05-26 |
HUP0400389A3 (en) | 2008-03-28 |
IL157713A0 (en) | 2004-03-28 |
CA2442210A1 (en) | 2002-10-10 |
CN1253435C (zh) | 2006-04-26 |
ES2318009T3 (es) | 2009-05-01 |
HK1057211A1 (en) | 2004-03-19 |
EP1373206B1 (de) | 2008-12-24 |
NZ528011A (en) | 2004-08-27 |
JP4303969B2 (ja) | 2009-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE525378T1 (de) | Himbacinanaloga als thrombinrezeptorantagonisten | |
DE60308850D1 (de) | Pyridinoylpiperidine als 5-ht1f agonisten | |
NO20050429D0 (no) | Substituert kinolin-CCR5-reseptorantagonister | |
ATE299866T1 (de) | Piperidinderivate verwendbar als ccr5 antagonisten | |
DE50304983D1 (de) | Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren | |
DE60330694D1 (de) | Pyrimidopyrimidone als kinaseinhibitoren | |
NO20052739D0 (no) | CCR5-antagonister som medikamenter | |
DE60134094D1 (de) | C7-taxanester als antitumormittel | |
ATE299865T1 (de) | Piperazinderivate verwendbar als ccr5 antagonisten | |
ATE299868T1 (de) | Dihydro-benzo (b) (1,4) diazepin-2-on-derivate als mglur2 antagonisten | |
NO20023424L (no) | Kortikotropin-frigjörende faktorantagonister | |
DE60305903D1 (de) | Tropanderivative als ccr5-modulatoren | |
DE60110844D1 (de) | Chinazolone derivate als alfa 1a/b adrenozeptor antagonisten | |
ATE392897T1 (de) | Chinolinderivate als npy antagonisten | |
ATE439344T1 (de) | Muscarin-antagonisten | |
PT1421075E (pt) | Derivados de piperdina uteis como antagonistas do ccr5 | |
DE60202761D1 (de) | Dihydro-benzo(b)(1,4)diazepin-2-on-derivate als mglur2 antagonisten | |
DE602004004278D1 (de) | 4-cycloalkylaminopyrazolopyrimidin als nmda/nr2b-antagonisten | |
ATE403651T1 (de) | 3-fluoro-piperidine als nmda/nr2b antagonisten | |
DE60332816D1 (de) | Nk1-antagonisten | |
DE60222693D1 (de) | Nk1-antagonisten | |
DE60316411D1 (de) | Thiazolderivate als npy-rezeptorantagonisten | |
ATE418542T1 (de) | Als ccr5-antagonisten verwendbare aryloxim- piperazine | |
ATE309994T1 (de) | Alkoxycarbonylaminobenzoesäure- oder alkoxycarbonylaminotetrazolylphenylderivate als ip-antagonisten | |
DE60226419D1 (de) | Somatostatin-antagonisten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |